Kirin / Seattle Genetics / Glaxosmithkline plc / /
Country
Germany / Sverige / Japan / United States / Danmark / /
Currency
USD / DKK / / /
Event
FDA Phase / Business Partnership / /
IndustryTerm
select products / cancer treatment / online chatkommunikation / online medier samt webcast af selskabernes / online dialog passer mig praktisk perfekt / blev skabt som et online mødested / /
Organization
FDA / European Union / /
Person
JAN VAN DE WINKEL Q / Jan Van de Winkel Ofatumumab / Jan Van de Winkel Genmab / Peter Hildebrandt / David Eatwell Genmab / Jan Van de Winkel kl / JAN VAN DE WINKEL / Jan Van de Winkel Janssen / Jan Van de Winkel Milestones / / /
Position
CEO / CFO / /
Product
Daratumumab / Inclacumab / /
Technology
ADC / antibodies / Ultimab technology / drug development / /
Q&A GENMAB 15. AUGUST 2013 MED JAN VAN DE WINKEL Q&A GENMAB 15. AUGUST 2013